Author:
Latham Michael D.,King Charles K.,Gorycki Peter,Macdonald Timothy L.,Ross Warren E.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology
Reference16 articles.
1. Boritzki TJ, Hann FS, Roberts BJ, Cheng YC, Jackson RC (1986) Inhibitory effects of fostriecin (CI-920) related analogs on eukaryotic type II topoisomerase. Proc Am Assoc Cancer Res 27: 276
2. Drake FH, Zimmerman JP, Bartus HF, Hofmann GA, Per SR, Mattern MR, Mirabelli CK, Johnson RK, Ross WE, Sullivan D, Crooke ST (1987) Purification of topoisomerase II from amsacrine-resistant P388 leukemia cells. J Biol Chem 262: 16739
3. Fesen MR, Pommier Y (1988) Topoisomerase inhibition by anticancer drugs is antagonized by distamycin. Proc Am Assoc Cancer Res 29: 276
4. Filipski J, Yin J, Kohn KW (1983) Reconstitution of intercalator-induced DNA scission by an active component from nuclear extracts. Biochim Biophys Acta 741: 116
5. Hilton BD, Misra R (1986) Magnetic resonance studies of fredericamycin A: evidence for O2-dependent free-radical formation. Biochemistry 25: 5533
Cited by
41 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献